Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first3,101 to 3,120 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| TIMP4 TIMP metallopeptidase inhibitor 4 | 7079 HGNC:11823 | 1 | 86 | 0 | 0 | 1,021 | 1,944 |
| PRKCG protein kinase C gamma | 5582 HGNC:9402 | 1 | 48 | 6 | 71 | 1,455 | 1,943 |
| SCAP SREBF chaperone | 22937 HGNC:30634 | 1 | 20 | 0 | 0 | 1,345 | 1,943 |
| CD6 CD6 molecule | 923 HGNC:1691 | 1 | 54 | 2 | 9 | 1,131 | 1,942 |
| LIG3 DNA ligase 3 | 3980 HGNC:6600 | 1 | 22 | 0 | 0 | 1,564 | 1,941 |
| HIF3A hypoxia inducible factor 3 subunit alpha | 64344 HGNC:15825 | 1 | 22 | 0 | 0 | 1,158 | 1,940 |
| MOK MOK protein kinase | 5891 HGNC:9833 | 1 | 35 | 0 | 0 | 708 | 1,940 |
| BAD BCL2 associated agonist of cell death | 572 HGNC:936 | 1 | 138 | 0 | 0 | 1,056 | 1,939 |
| IGKV3D-25 immunoglobulin kappa variable 3D-25 (pseudogene) | 28873 HGNC:5826 | 0 | 0 | 0 | 0 | 1,390 | 1,938 |
| FLCN folliculin | 201163 HGNC:27310 | 1 | 24 | 0 | 0 | 954 | 1,937 |
| PARD3 par-3 family cell polarity regulator | 56288 HGNC:16051 | 1 | 22 | 0 | 0 | 1,605 | 1,937 |
| MAPK11 mitogen-activated protein kinase 11 | 5600 HGNC:6873 | 1 | 65 | 3 | 268 | 1,197 | 1,936 |
| TRIM24 tripartite motif containing 24 | 8805 HGNC:11812 | 1 | 39 | 0 | 0 | 1,089 | 1,935 |
| CPB1 carboxypeptidase B1 | 1360 HGNC:2299 | 1 | 70 | 0 | 0 | 1,021 | 1,934 |
| ABCC6 ATP binding cassette subfamily C member 6 | 368 HGNC:57 | 1 | 17 | 0 | 0 | 792 | 1,933 |
| CDC45 cell division cycle 45 | 8318 HGNC:1739 | 1 | 80 | 0 | 0 | 1,092 | 1,933 |
| RECK reversion inducing cysteine rich protein with kazal motifs | 8434 HGNC:11345 | 1 | 43 | 0 | 0 | 861 | 1,933 |
| CHD1 chromodomain helicase DNA binding protein 1 | 1105 HGNC:1915 | 1 | 23 | 0 | 0 | 1,560 | 1,932 |
| GFM1 G elongation factor mitochondrial 1 | 85476 HGNC:13780 | 1 | 36 | 0 | 0 | 1,012 | 1,932 |
| AGR2 anterior gradient 2, protein disulphide isomerase family member | 10551 HGNC:328 | 1 | 128 | 0 | 0 | 941 | 1,931 |
Code
curl "https://conductscience.org/api/genes/v1?page=156"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=156
{
"data": {
"total": 193990,
"results": [
{
"id": "7079",
"title": "TIMP4: TIMP metallopeptidase inhibitor 4",
"summary": "NCBI Gene 7079. 1 protein, 86 patents, 0 drugs, 0 trials, 1,021 NIH grants and 1,944 papers.",
"record": "/library/genes/7079",
"gene_id": 7079,
"symbol": "TIMP4",
"name": "TIMP metallopeptidase inhibitor 4",
"hgnc_id": "HGNC:11823",
"counts": {
"proteins": 1,
"patents": 86,
"drugs": 0,
"trials": 0,
"grants": 1021,
"papers": 1944
}
},
{
"id": "5582",
"title": "PRKCG: protein kinase C gamma",
"summary": "NCBI Gene 5582. 1 protein, 48 patents, 6 drugs, 71 trials, 1,455 NIH grants and 1,943 papers.",
"record": "/library/genes/5582",
"gene_id": 5582,
"symbol": "PRKCG",
"name": "protein kinase C gamma",
"hgnc_id": "HGNC:9402",
"counts": {
"proteins": 1,
"patents": 48,
"drugs": 6,
"trials": 71,
"grants": 1455,
"papers": 1943
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=157",
"request_id": "o4EH-ENLT61b_i7h"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant